Without adapting JCA to include assessment of real world data (RWD) and broader benefits, vaccines may be undervalued, ...

Biogen and Eisai have announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an ...

Merck (known as MSD outside the US and Canada) has entered into a definitive agreement to acquire Cidara Therapeutics, a ...

Johnson & Johnson (J&J) has received a positive recommendation from the UK’s National Institute for Health and Care ...

Novartis has reported positive top-line results from the phase 3 KALUMA trial evaluating KLU156 (ganaplacide/lumefantrine, or ...

InflaRx – a biopharmaceutical company developing anti-inflammatory therapeutics targeting the complement system – has ...

AstraZeneca has reported positive full results from its phase 3 NATRON trial evaluating Fasenra (benralizumab) for the ...

For decades, menopause has been swept under the rug, or into the dark corners of clinicians’ offices, often dismissed as ...

PMEA returned on 19 November to the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

VML Portugal has announced the launch of VML Health, with pharma communications veteran Mariana Marta dos Santos being ...

Amgen has reported positive results from its phase 3 VESALIUS-CV trial, which demonstrated that Repatha (evolocumab) ...

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional ...